JP2018512154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512154A5 JP2018512154A5 JP2017553230A JP2017553230A JP2018512154A5 JP 2018512154 A5 JP2018512154 A5 JP 2018512154A5 JP 2017553230 A JP2017553230 A JP 2017553230A JP 2017553230 A JP2017553230 A JP 2017553230A JP 2018512154 A5 JP2018512154 A5 JP 2018512154A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- subject
- composition
- chimeric protein
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1506223.5 | 2015-04-13 | ||
| GBGB1506223.5A GB201506223D0 (en) | 2015-04-13 | 2015-04-13 | Chimeric protein |
| PCT/GB2016/051019 WO2016166521A1 (en) | 2015-04-13 | 2016-04-12 | Chimeric protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512154A JP2018512154A (ja) | 2018-05-17 |
| JP2018512154A5 true JP2018512154A5 (https=) | 2019-02-28 |
| JP6704411B2 JP6704411B2 (ja) | 2020-06-03 |
Family
ID=53333686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017553230A Expired - Fee Related JP6704411B2 (ja) | 2015-04-13 | 2016-04-12 | キメラタンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10869911B2 (https=) |
| EP (1) | EP3283526B1 (https=) |
| JP (1) | JP6704411B2 (https=) |
| CN (1) | CN107531804A (https=) |
| AU (1) | AU2016250200B2 (https=) |
| CA (1) | CA2981846A1 (https=) |
| ES (1) | ES2749903T3 (https=) |
| GB (1) | GB201506223D0 (https=) |
| HK (1) | HK1243107B (https=) |
| WO (1) | WO2016166521A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201519900D0 (en) * | 2015-11-11 | 2015-12-23 | Ucl Business Plc | Chimeric antigen receptor |
| CN108395482B (zh) | 2017-02-08 | 2021-02-05 | 西比曼生物科技（香港）有限公司 | 一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定 |
| GB201716728D0 (en) | 2017-10-12 | 2017-11-29 | Autolus Ltd | Cell |
| AU2019403393B2 (en) * | 2018-12-20 | 2026-04-16 | The University Of Chicago | Methods and compositions related to therapeutic peptides for cancer therapy |
| AU2020388637A1 (en) * | 2019-11-21 | 2022-07-07 | Remedium Bio, Inc. | Growth factor restoration |
| CN113402612A (zh) | 2020-03-17 | 2021-09-17 | 西比曼生物科技（香港）有限公司 | 靶向cd19和cd20的联合嵌合抗原受体及其应用 |
| CN115397863A (zh) * | 2020-04-01 | 2022-11-25 | 基因医疗免疫疗法有限责任公司 | Cd3融合蛋白及其用途 |
| US12516307B2 (en) | 2020-08-18 | 2026-01-06 | Onchilles Pharma, Inc. | Modified porcine pancreatic elastase proteins |
| KR20230016156A (ko) * | 2021-07-21 | 2023-02-01 | 한국생명공학연구원 | 신규한 키메릭 항원 수용체 및 이를 발현하는 면역세포 |
| JP2025540894A (ja) * | 2022-11-29 | 2025-12-16 | マルコープ・バイオディスカバリーズ・リミテッド | 新規ｃｄ２０タンパク質 |
| KR20250131823A (ko) | 2023-03-31 | 2025-09-03 | 아벨제타 인크. | Cd20 및 bcma를 표적화하는 이중특이적 키메라 항원 수용체 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9914650D0 (en) * | 1999-06-24 | 1999-08-25 | Angyogene Pharmaceuticals Ltd | Chimeric proteins mediating targeted apoptosis |
| US9382327B2 (en) | 2006-10-10 | 2016-07-05 | Vaccinex, Inc. | Anti-CD20 antibodies and methods of use |
| TR201904484T4 (tr) * | 2009-11-03 | 2019-05-21 | Hope City | Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt). |
| CA2891764A1 (en) | 2012-11-19 | 2014-05-22 | Baliopharm Ag | Recombinant bispecific antibody binding to cd20 and cd95 |
| JP2017100947A (ja) * | 2014-03-31 | 2017-06-08 | 株式会社オーダーメードメディカルリサーチ | 目的抗原に対する抗体の作製方法 |
-
2015
- 2015-04-13 GB GBGB1506223.5A patent/GB201506223D0/en not_active Ceased
-
2016
- 2016-04-12 WO PCT/GB2016/051019 patent/WO2016166521A1/en not_active Ceased
- 2016-04-12 CN CN201680021442.1A patent/CN107531804A/zh active Pending
- 2016-04-12 ES ES16717433T patent/ES2749903T3/es active Active
- 2016-04-12 HK HK18102740.9A patent/HK1243107B/en not_active IP Right Cessation
- 2016-04-12 AU AU2016250200A patent/AU2016250200B2/en not_active Ceased
- 2016-04-12 US US15/565,914 patent/US10869911B2/en not_active Expired - Fee Related
- 2016-04-12 EP EP16717433.3A patent/EP3283526B1/en active Active
- 2016-04-12 CA CA2981846A patent/CA2981846A1/en not_active Abandoned
- 2016-04-12 JP JP2017553230A patent/JP6704411B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018512154A5 (https=) | ||
| JP6997267B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| CN112638947B (zh) | 用于治疗实体瘤的嵌合抗原受体细胞 | |
| JP7029401B2 (ja) | 抗ｒｏｒ１抗体およびその使用 | |
| JP6886491B2 (ja) | 前立腺特異幹細胞抗原に対する抗体およびその使用 | |
| JP6196338B2 (ja) | 診断および治療のための腫瘍関連抗原の同定 | |
| KR102875986B1 (ko) | Il27 수용체 결합과 관련된 조성물 및 방법 | |
| EP3378488A1 (en) | Method for enhancing humoral immune response | |
| KR20110066195A (ko) | 종간특이적 ｐｓｍａｘｃｄ3 이중특이적 단쇄 항체 | |
| KR20090021217A (ko) | 조혈 줄기세포 증가 촉진제 | |
| CN115698081A (zh) | 靶向bcma的嵌合抗原受体及其用途 | |
| JP7839238B2 (ja) | ｍＲＮＡディスプレイ抗体ライブラリー及び方法 | |
| CN118871471A (zh) | 用于肿瘤靶向的嵌合抗原受体 | |
| US20240263355A1 (en) | mRNA display antibody library and methods | |
| Rutkowski et al. | Clr-a: a novel immune-related C-type lectin-like molecule exclusively expressed by mouse gut epithelium | |
| TW201111510A (en) | Recombinant nucleotide sequence, cell or vector containing the recombinant nucleotide sequence, recombinant single chain anti-polyethylene glycol membrane antibody encoded thereof and method for using the cell containing the recombinant nucleotide sequen | |
| BR112020016374A2 (pt) | Métodos e composições para direcionar células treg | |
| KR20230124912A (ko) | 키메라 수용체 및 이의 사용 방법 | |
| JP2023516089A (ja) | がんの治療のための組成物及び方法 | |
| US20240228620A1 (en) | Multispecific proteins and related methods | |
| CN111393527B (zh) | 可结合pd-l1的多肽及其应用 | |
| NL2021037B1 (en) | TEIPP neoantigens and uses thereof | |
| JP2026511106A (ja) | 抗クローディン－１抗体を使用したがん治療のためのバイオマーカー | |
| HK40111286A (zh) | 用於肿瘤靶向的嵌合抗原受体 | |
| JP2024529467A5 (https=) |